ENSG00000291006 and ovarian carcinoma: The results from the apoptosis rates showed that when the combination of cisplatin and 3-MA or niraparib and 3-MA treatment resulted in significantly more apoptosis of ovarian cancer cells than the group treated with cisplatin or niraparib alone, and the difference in apoptosis rate reduced by knockdown of LOC730101 was reverted (Fig. S5A, S5E).